A Novel PI3K Inhibitor PIK-C98 Displays Potent Preclinical Activity Against Multiple Myeloma
Oncotarget - United States
doi 10.18632/oncotarget.2688
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 4, 2014
Authors
Publisher
Impact Journals, LLC